Jubilant Life Sciences turns black in Q3

30 Jan 2013 Evaluate

Jubilant Life Sciences has reported results for third quarter ended December 31, 2012.

The company, on consolidated basis, has reported net profit of Rs 26.69 crore for the quarter as compared to a net loss of Rs 78.39 crore for the same quarter in the previous year. Total income from operation of the company has increased by 19.27% at Rs 1306.39 crore for quarter under review as compared to Rs 1095.25 crore for the quarter ended December 31, 2011.

Jubilant Life Sciences is an integrated Pharmaceuticals and Life Sciences Company. It is the largest Custom Research and Manufacturing Services (CRAMS) player and a leading Drug Discovery and Development Solution provider out of India.

Jubilant Pharmova Share Price

1076.40 7.20 (0.67%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×